Int J Angiol 2016; 25(05): e139-e141
DOI: 10.1055/s-0035-1555750
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Elevated Factor VIII Levels Associated with Acute Graft Occlusion and Arterial and Venous Thrombosis After Off Pump CABG

Crystal A. Kyaw
1   Department of Cardiovascular and Thoracic Surgery, Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York
,
Pey-Jen Yu
1   Department of Cardiovascular and Thoracic Surgery, Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York
,
Frank Manetta
1   Department of Cardiovascular and Thoracic Surgery, Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
31 July 2015 (online)

Abstract

Factor VIII is a common acute phase reactant and elevated levels confer an increased risk of thrombosis. Such thrombotic events have been documented in the literature, though to a limited extent. We present the case of a 54-year-old man presenting with a non–Q-wave myocardial infarction who was found to have triple vessel disease and subsequently underwent a 4-vessel coronary artery bypass grafting (CABG). Postoperatively, he was found to have multiple occluded vessels, deep vein thromboses, and a cerebrovascular accident (CVA). A hypercoagulability work-up revealed significantly elevated levels of factor VIII at 377% normal, which likely contributed to these thrombotic events. Further exploration is warranted to elucidate causal mechanisms of these thrombotic events, particularly of multiple graft occlusions, and to guide clinical decision making with regards to anticoagulation and stent management.

 
  • References

  • 1 Jenkins PV, Rawley O, Smith OP, O'Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol 2012; 157 (6) 653-663
  • 2 Glueck CJ, Munjal J, Aregawi D , et al. Thrombophilia-hypofibrinolysis and atherothrombotic cardiovascular disease < or = age 45 years. Transl Res 2007; 150 (2) 93-100
  • 3 Hess CN, Lopes RD, Gibson CM , et al. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation 2014; 130 (17) 1445-1451
  • 4 Edelman JJ, Reddel CJ, Kritharides L , et al. Natural history of hypercoagulability in patients undergoing coronary revascularization and effect of preoperative myocardial infarction. J Thorac Cardiovasc Surg 2014; 148 (2) 536-543
  • 5 Lison S, Weiss G, Spannagl M, Heindl B. Postoperative changes in procoagulant factors after major surgery. Blood Coagul Fibrinolysis 2011; 22 (3) 190-196
  • 6 Kennedy DM, Alaniz C. Apparent argatroban resistance in a patient with elevated factor VIII levels. Ann Pharmacother 2013; 47 (7-8) e29
  • 7 Thota R, Ganti AK, Subbiah S. Apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor VIII levels. J Thromb Thrombolysis 2012; 34 (1) 132-134
  • 8 Davierwala PM, Mohr FW. Bilateral internal mammary artery grafting: Rationale and evidence. Int J Surg 2015; 16 (Pt B): 133-139
  • 9 Benedetto U, Raja SG, Albanese A, Amrani M, Biondi-Zoccai G, Frati G. Searching for the second best graft for coronary artery bypass surgery: a network meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg 2015; 47 (1) 59-65 , discussion 65
  • 10 Costa C, Alves M, Durão D, Leal M, Monteiro I. Elevated factor VIII in a patient with acute coronary syndrome. Rev Port Cardiol 2014; 33 (3) 181.e1-181.e4
  • 11 Albert NE, Hamarich AY, Joshi A. Elevated factor VIII: an unfamiliar risk factor for cerebral venous thrombosis. J Am Osteopath Assoc 2012; 112 (3) 140-141
  • 12 Lasek-Bal A, Puz P, Kazibutowska Z. Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases. Neuropsychiatr Dis Treat 2013; 9: 847-852